The table below lists the top 20 global drug companies based on sales in 2009:
|S.No.||Company||Ticker||2009 Revenues in US $ (Milllions)|
|6||Merck & Co.||MRK||$26,929|
|7||Johnson & Johnson||JNJ||$22,520|
|8||Eli Lilly & Co.||LLY||$20,629|
|11||Takeda Chem Ind.||TKPYY||$14,204|
Source: Contract Pharma
Otsuka, Gilead and Mylan are new to this list. Half of the companies ranked 11-20 are based in Japan. Though currently ranked at number 13, Israel-based Teva (TEVA), the world’s largest generic drug maker, has revenue goals that could propel it into the top 7 ranks in the next few years. US-based Gilead (GILD) primarily focuses on developing drugs for life-threatening diseases diseases such as HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.